PURPOSE: Aspartate β-hydroxylase (ASPH) contributes to carcinogenesis by promoting tumor cell proliferation, migration, and invasion. The enzymatic activity of ASPH can be inhibited by small molecule inhibitors that have been shown to have anti-metastatic activity in rodent models. ASPH has also been shown to inhibit the activation of natural killer (NK) cells. Therefore, this study aimed to investigate the effect of ASPH inhibition on the induction of anti-tumor immunity and to analyze the immune cells involved. METHODS: In the mouse TC-1/A9 model characterized by reversible downregulation of major histocompatibility class I (MHC-I) molecules, ASPH inhibition was combined with stimulation of innate and/or adaptive immunity, and the anti-tumor response was analyzed by evaluation of tumor growth, in vivo depletion of immune cell subpopulations, and ELISPOT assay. Characteristics of immune cells in the spleen and tumor were determined by flow cytometry and single-cell RNA sequencing (scRNA-seq). RESULTS: ASPH inhibition did not reduce tumor growth or promote the anti-tumor effect of innate immunity stimulation with the synthetic oligonucleotide ODN1826, but it significantly enhanced tumor growth reduction induced by DNA vaccination. In vivo immune cell depletion suggested that CD8+ T cells played a critical role in this immunity stimulated by combined treatment with ASPH inhibition and DNA vaccination. ASPH inhibition also significantly enhanced the specific response of CD8+ T cells induced by DNA vaccination in splenocytes, as detected by ELISPOT assay, and reduced the number of regulatory T cells in tumors. scRNA-seq confirmed the improved activation of CD8+ T cells in tumor-infiltrating cells after combined therapy with DNA vaccination and ASPH inhibition. It also showed activation of NK cells, macrophages, and dendritic cells in tumors. CONCLUSION: ASPH inhibition stimulated T-cell-mediated adaptive immunity induced by DNA vaccination. Different types of lymphoid and myeloid cells were likely involved in the activated immune response that was efficient against tumors with MHC-I downregulation, which are often resistant to T-cell-based therapies. Due to different types of activated immune cells, ASPH inhibition could improve immunotherapy for tumors with various MHC-I expression levels.

Czech Centre for Phenogenomics and Laboratory of Transgenic Models of Diseases Institute of Molecular Genetics of the Czech Academy of Sciences Prague Czech Republic

Department of Genetics and Microbiology Faculty of Science Charles University BIOCEV Vestec Czech Republic

Department of Pharmaceutical Sciences College of Pharmacy Glendale Midwestern University Glendale AZ USA

Zobrazit více v PubMed

Yang H, Song K, Xue T, et al. The distribution and expression profiles of human aspartyl/asparaginyl beta-hydroxylase in tumor cell lines and human tissues. PubMed DOI

Zheng W, Wang X, Hu J, Bai B, Zhu H. Diverse molecular functions of aspartate β‑hydroxylase in cancer. PubMed DOI PMC

Gan X, Li S, Wang Y, et al. Aspartate β-hydroxylase serves as a prognostic biomarker for neoadjuvant chemotherapy in gastric cancer. PubMed DOI PMC

Lavaissiere L, Jia S, Nishiyama M, et al. Overexpression of human aspartyl(asparaginyl)beta-hydroxylase in hepatocellular carcinoma and cholangiocarcinoma. PubMed DOI PMC

Dong X, Lin Q, Aihara A, et al. Aspartate β-hydroxylase expression promotes a malignant pancreatic cellular phenotype. PubMed DOI PMC

Cantarini MC, de la Monte SM, Pang M, et al. Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms. PubMed DOI

Hou G, Xu B, Bi Y, et al. Recent advances in research on aspartate β-hydroxylase (ASPH) in pancreatic cancer: a brief update. PubMed DOI PMC

Moon RT, Kohn AD, De Ferrari GV, Kaykas A. WNT and beta-catenin signalling: diseases and therapies. PubMed DOI

Kanwal M, Smahel M, Olsen M, Smahelova J, Tachezy R. Aspartate β-hydroxylase as a target for cancer therapy. PubMed DOI PMC

Dinchuk JE, Focht RJ, Kelley JA, et al. Absence of post-translational aspartyl β-hydroxylation of epidermal growth factor domains in mice leads to developmental defects and an increased incidence of intestinal neoplasia. PubMed DOI

Lin Q, Chen X, Meng F, et al. ASPH-notch axis guided exosomal delivery of prometastatic secretome renders breast cancer multi-organ metastasis. PubMed DOI PMC

Yuan X, Wu H, Xu H, et al. Notch signaling: an emerging therapeutic target for cancer treatment. PubMed DOI

Zhou Y, Yuan Y, Zhang Q, Shen Y, Chen W, Yan L. Downregulation of SLC14A1 expression indicates poor prognosis and promotes the progression of non-small cell lung cancer. PubMed

Zou Q, Hou Y, Wang H, et al. Hydroxylase activity of ASPH promotes hepatocellular carcinoma metastasis through epithelial-to-mesenchymal transition pathway. PubMed DOI PMC

Huang C-K, Iwagami Y, Zou J, et al. Aspartate beta-hydroxylase promotes cholangiocarcinoma progression by modulating RB1 phosphorylation. PubMed DOI PMC

Ogawa K, Lin Q, Li L, et al. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway. PubMed DOI PMC

Iwagami Y, Huang C-K, Olsen MJ, et al. Aspartate β-hydroxylase modulates cellular senescence through glycogen synthase kinase 3β in hepatocellular carcinoma. PubMed DOI PMC

Kanwal M, Smahelova J, Ciharova B, et al. Aspartate β-hydroxylase regulates expression of Ly6 genes. PubMed DOI PMC

Radtke F, Fasnacht N, Macdonald HR. Notch signaling in the immune system. PubMed DOI

Radtke F, MacDonald HR, Tacchini-Cottier F. Regulation of innate and adaptive immunity by Notch. PubMed DOI

Wang Y-C, He F, Feng F, et al. Notch signaling determines the M1 versus M2 polarization of macrophages in antitumor immune responses. PubMed DOI

Osborne BA, Minter LM. Notch signalling during peripheral T-cell activation and differentiation. PubMed DOI

Huyan T, Li Q, Ye LJ, et al. Inhibition of human natural killer cell functional activity by human aspartyl β-hydroxylase. PubMed DOI

Brewitz L, Tumber A, Thalhammer A, Salah E, Christensen KE, Schofield CJ. Synthesis of novel pyridine-carboxylates as small-molecule inhibitors of human aspartate/asparagine-β-hydroxylase. PubMed DOI PMC

Aihara A, Huang CK, Olsen MJ, et al. A cell-surface β-hydroxylase is a biomarker and therapeutic target for hepatocellular carcinoma. PubMed DOI PMC

Huang CK, Iwagami Y, Aihara A, et al. Anti-tumor effects of second generation β-hydroxylase inhibitors on cholangiocarcinoma development and progression. PubMed DOI PMC

Nagaoka K, Ogawa K, Ji C, et al. Targeting aspartate beta-hydroxylase with the small molecule inhibitor MO-I-1182 suppresses cholangiocarcinoma metastasis. PubMed DOI

Smahel M, Síma P, Ludvíková V, Marinov I, Pokorná D, Vonka V. Immunisation with modified HPV16 E7 genes against mouse oncogenic TC-1 cell sublines with downregulated expression of MHC class I molecules. PubMed DOI

Smahel M, Polakova I, Duskova M, Ludvikova V, Kastankova I. The effect of helper epitopes and cellular localization of an antigen on the outcome of gene gun DNA immunization. PubMed DOI

Smahel M, Síma P, Ludvíková V, Vonka V. Modified HPV16 E7 genes as DNA vaccine against E7-containing oncogenic cells. PubMed DOI

Kaštánková I, Poláková I, Dušková M, Šmahel M. Combined cancer immunotherapy against Aurora kinase A. PubMed DOI

Grosjean C, Quessada J, Nozais M, Loosveld M, Payet-Bornet D, Mionnet C. Isolation and enrichment of mouse splenic T cells for and T cell receptor stimulation assays. PubMed DOI PMC

Zheng GXY, Terry JM, Belgrader P, et al. Massively parallel digital transcriptional profiling of single cells. PubMed DOI PMC

Hao Y, Hao S, Andersen-Nissen E, et al. Integrated analysis of multimodal single-cell data. PubMed DOI PMC

Germain PL, Lun A, Garcia Meixide C, Macnair W, Robinson MD. Doublet identification in single-cell sequencing data using scDblFinder. PubMed DOI PMC

Ertöz L, Steinbach M, Kumar V. Finding clusters of different sizes, shapes, and densities in noisy, high dimensional data. In: Proceedings of the 2003 SIAM International Conference on Data Mining. Society for Industrial and Applied Mathematics; 2003:47–58. doi: 10.1137/1.9781611972733.5. DOI

McInnes L, Healy J, Melville J. UMAP: uniform manifold approximation and projection for dimension reduction. DOI

Tabula Muris Consortium, Overall coordination, Logistical coordination, et al. Single-cell transcriptomics of 20 mouse organs creates a Tabula Muris. PubMed DOI PMC

Ekiz HA, Conley CJ, Stephens WZ, O’Connell RM. CIPR: a web-based R/shiny app and R package to annotate cell clusters in single cell RNA sequencing experiments. PubMed DOI PMC

Franzén O, Gan LM, Björkegren JLM. PanglaoDB: a web server for exploration of mouse and human single-cell RNA sequencing data. PubMed DOI PMC

Patil A, Patil A. CellKb Immune: a manually curated database of mammalian hematopoietic marker gene sets for rapid cell type identification. DOI

Cao Y, Wang X, Peng G. SCSA: a cell type annotation tool for single-cell RNA-seq data. PubMed DOI PMC

Zhang X, Lan Y, Xu J, et al. CellMarker: a manually curated resource of cell markers in human and mouse. PubMed DOI PMC

Morgan M, Shepherd L. AnnotationHub: client to access AnnotationHub resources. DOI

Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. PubMed DOI PMC

Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. PubMed DOI PMC

Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. PubMed DOI PMC

Wickham H. Ggplot2. DOI

Kuleshov MV, Jones MR, Rouillard AD, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. PubMed DOI PMC

Liberzon A, Subramanian A, Pinchback R, Thorvaldsdóttir H, Tamayo P, Mesirov JP. Molecular signatures database (MSigDB) 3.0. PubMed DOI PMC

Jin S, Guerrero-Juarez CF, Zhang L, et al. Inference and analysis of cell-cell communication using CellChat. PubMed DOI PMC

Grzelak A, Polakova I, Smahelova J, et al. Experimental combined immunotherapy of tumours with major histocompatibility complex class I downregulation. PubMed DOI PMC

Sprooten J, Vanmeerbeek I, Datsi A, et al. Lymph node and tumor-associated PD-L1+ macrophages antagonize dendritic cell vaccines by suppressing CD8+ T cells. PubMed DOI PMC

Lhotakova K, Grzelak A, Polakova I, Vackova J, Smahel M. Establishment and characterization of a mouse tumor cell line with irreversible downregulation of MHC class I molecules. PubMed DOI

Park JH, Lee HK. Function of γδ T cells in tumor immunology and their application to cancer therapy. PubMed DOI PMC

Li L, Yang L, Jiang D. Research progress of CD80 in the development of immunotherapy drugs. PubMed DOI PMC

Uhlen M, Oksvold P, Fagerberg L, et al. Towards a knowledge-based Human Protein Atlas. PubMed DOI

Fu C, Jiang A. Dendritic cells and CD8 T cell immunity in tumor microenvironment. PubMed DOI PMC

Xiao Z, Wang R, Wang X, et al. Impaired function of dendritic cells within the tumor microenvironment. PubMed DOI PMC

Ogawa K, Lin Q, Li L, et al. Prometastatic secretome trafficking via exosomes initiates pancreatic cancer pulmonary metastasis. PubMed DOI PMC

de Vries NL, van de Haar J, Veninga V, et al. γδ T cells are effectors of immunotherapy in cancers with HLA class I defects. PubMed DOI PMC

Han J, Dong L, Wu M, Ma F. Dynamic polarization of tumor-associated macrophages and their interaction with intratumoral T cells in an inflamed tumor microenvironment: from mechanistic insights to therapeutic opportunities. PubMed DOI PMC

Beck JD, Diken M, Suchan M, et al. Long-lasting mRNA-encoded interleukin-2 restores CD8+ T cell neoantigen immunity in MHC class I-deficient cancers. PubMed DOI

Lerner EC, Woroniecka KI, D’Anniballe VM, et al. CD8+ T cells maintain killing of MHC-I-negative tumor cells through the NKG2D–NKG2DL axis. PubMed DOI PMC